Perseus Proteomics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,515	1,667	1,541	2,444	3,214
Cash & Short-Term Investments	1,515	1,667	1,541	2,444	3,214
Cash Growth	-9.12%	8.18%	-36.95%	-23.96%	200.65%
Accounts Receivable	18	22	13	9	10
Other Receivables	34	50	70	41	35
Receivables	52	72	83	50	45
Inventory	7	5	4	3	3
Prepaid Expenses	8	11	5	7	4
Other Current Assets	26	20	17	10	24
Total Current Assets	1,608	1,775	1,650	2,514	3,290
Long-Term Investments	14	42	42	51	9
Other Long-Term Assets	1	1	1	1	1
Total Assets	1,623	1,818	1,693	2,566	3,300
Accounts Payable	1	-	1	1	-
Accrued Expenses	32	41	57	28	11
Current Income Taxes Payable	27	79	66	66	134
Other Current Liabilities	5	4	4	16	3
Total Current Liabilities	65	124	128	111	148
Other Long-Term Liabilities	341	262	167	59	-
Total Liabilities	406	386	295	170	148
Common Stock	751	2,437	1,971	1,939	1,939
Additional Paid-In Capital	1,104	2,723	2,256	2,225	2,225
Retained Earnings	-718	-3,808	-2,903	-1,799	-1,012
Comprehensive Income & Other	80	80	74	31	-
Shareholders' Equity	1,217	1,432	1,398	2,396	3,152
Total Liabilities & Equity	1,623	1,818	1,693	2,566	3,300
Net Cash (Debt)	1,515	1,667	1,541	2,444	3,214
Net Cash Growth	-9.12%	8.18%	-36.95%	-23.96%	200.65%
Net Cash Per Share	101.63	116.83	130.72	207.83	292.27
Filing Date Shares Outstanding	15.38	14.75	11.85	11.76	11.75
Total Common Shares Outstanding	15.38	14.75	11.85	11.76	11.75
Working Capital	1,543	1,651	1,522	2,403	3,142
Book Value Per Share	79.14	97.09	118.00	203.75	268.36
Tangible Book Value	1,217	1,432	1,398	2,396	3,152
Tangible Book Value Per Share	79.14	97.09	118.00	203.75	268.36